R. Moshref, L. Moshref, A. Sabbagh, K. Bajunaid, M. Alyousef, S. Baeesa, R. Daghistani, FA Alhalawani, MA Aljehani, NM Shibriq, WA Saber, AB Khojah, RM Alsayed
{"title":"P.127 沙特阿拉伯一家三级医院脑肿瘤切除术患者的生活质量(QoL)(采用 EORTC QoL-C30 和 BN20 测量","authors":"R. Moshref, L. Moshref, A. Sabbagh, K. Bajunaid, M. Alyousef, S. Baeesa, R. Daghistani, FA Alhalawani, MA Aljehani, NM Shibriq, WA Saber, AB Khojah, RM Alsayed","doi":"10.1017/cjn.2024.228","DOIUrl":null,"url":null,"abstract":"Background: Quality of life (QoL) is the awareness of individuals’ well-being in life in physical, personal, mental and social wellbeing and needs to be addressed in brain tumor patients. Methods: A retrospective study conducted in 2017 in a single academic center that included patients diagnosed with brain tumors in a 10 year period. The assessment of the QoL was done using the European Organization for Research and Treatment of Cancer (EORTC), a standardized model (QLQ-C30) that assess several domains (Global Health, Physical function, Role functioning, Emotional Functioning, Cognitive functioning, social functioning and symptoms domain) and Brain cancer model (BN20) to assess symptoms to evaluate all aspects of wellbeing. Results: The total number of patients included in this study is 76 patients with no gender predilection. The most common brain tumor was meningioma by 40% followed by glioma/ others. More than half of the brain tumor patients had a WHO grade I (65%), intermediate grading grade II (15%) and higher grading grade III/IV (20%). The scales and measurements of functioning in life were low in all types of brain tumors. Conclusions: Quality of life in brain tumor patients seemed poor regardless of the type. Further prospective studies are needed to assess QoL worldwide.","PeriodicalId":9571,"journal":{"name":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","volume":"11 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"P.127 Quality of life (QoL) using EORTC QoL-C30 and BN20 among patients who underwent brain tumor resection in a tertiary hospital in Saudi Arabia\",\"authors\":\"R. Moshref, L. Moshref, A. Sabbagh, K. Bajunaid, M. Alyousef, S. Baeesa, R. Daghistani, FA Alhalawani, MA Aljehani, NM Shibriq, WA Saber, AB Khojah, RM Alsayed\",\"doi\":\"10.1017/cjn.2024.228\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Quality of life (QoL) is the awareness of individuals’ well-being in life in physical, personal, mental and social wellbeing and needs to be addressed in brain tumor patients. Methods: A retrospective study conducted in 2017 in a single academic center that included patients diagnosed with brain tumors in a 10 year period. The assessment of the QoL was done using the European Organization for Research and Treatment of Cancer (EORTC), a standardized model (QLQ-C30) that assess several domains (Global Health, Physical function, Role functioning, Emotional Functioning, Cognitive functioning, social functioning and symptoms domain) and Brain cancer model (BN20) to assess symptoms to evaluate all aspects of wellbeing. Results: The total number of patients included in this study is 76 patients with no gender predilection. The most common brain tumor was meningioma by 40% followed by glioma/ others. More than half of the brain tumor patients had a WHO grade I (65%), intermediate grading grade II (15%) and higher grading grade III/IV (20%). The scales and measurements of functioning in life were low in all types of brain tumors. Conclusions: Quality of life in brain tumor patients seemed poor regardless of the type. Further prospective studies are needed to assess QoL worldwide.\",\"PeriodicalId\":9571,\"journal\":{\"name\":\"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques\",\"volume\":\"11 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1017/cjn.2024.228\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/cjn.2024.228","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:生活质量(QoL)是对个人在身体、个人、精神和社会福祉等方面生活幸福感的认识,需要在脑肿瘤患者中得到关注。研究方法2017年,在一家学术中心开展了一项回顾性研究,研究对象包括10年内确诊的脑肿瘤患者。QoL评估采用欧洲癌症研究和治疗组织(EORTC)的标准化模型(QLQ-C30),该模型评估多个领域(全球健康、身体功能、角色功能、情感功能、认知功能、社会功能和症状领域),并采用脑癌模型(BN20)评估症状,以评估福祉的各个方面。研究结果本研究共纳入 76 名患者,无性别偏好。最常见的脑肿瘤是脑膜瘤,占 40%,其次是胶质瘤/其他。半数以上的脑肿瘤患者属于世卫组织 I 级(65%)、中级 II 级(15%)和高级 III/IV 级(20%)。在所有类型的脑肿瘤中,生活功能的量表和测量结果都很低。结论无论哪种类型的脑瘤,脑瘤患者的生活质量似乎都很差。需要进一步开展前瞻性研究,在全球范围内评估生活质量。
P.127 Quality of life (QoL) using EORTC QoL-C30 and BN20 among patients who underwent brain tumor resection in a tertiary hospital in Saudi Arabia
Background: Quality of life (QoL) is the awareness of individuals’ well-being in life in physical, personal, mental and social wellbeing and needs to be addressed in brain tumor patients. Methods: A retrospective study conducted in 2017 in a single academic center that included patients diagnosed with brain tumors in a 10 year period. The assessment of the QoL was done using the European Organization for Research and Treatment of Cancer (EORTC), a standardized model (QLQ-C30) that assess several domains (Global Health, Physical function, Role functioning, Emotional Functioning, Cognitive functioning, social functioning and symptoms domain) and Brain cancer model (BN20) to assess symptoms to evaluate all aspects of wellbeing. Results: The total number of patients included in this study is 76 patients with no gender predilection. The most common brain tumor was meningioma by 40% followed by glioma/ others. More than half of the brain tumor patients had a WHO grade I (65%), intermediate grading grade II (15%) and higher grading grade III/IV (20%). The scales and measurements of functioning in life were low in all types of brain tumors. Conclusions: Quality of life in brain tumor patients seemed poor regardless of the type. Further prospective studies are needed to assess QoL worldwide.